A cure for the previously incurable. That’s the big promise of Advanced Therapy Medicinal Products (ATMPs), and it’s attracting big numbers. In 2020 alone, the global ATMP industry raised $19.9B in annual financing, a 200% increase over 2019.
Capital markets in South Asia have stepped up their efforts to encourage companies to be transparent about their impacts – thanks to engagements by sustainability standards sett Global Reporting Initiative (GRI) with stock exchanges and regulators.
With the UN climate change conference – COP26 – continuing this week in Glasgow, it’s obvious that there is consensus among a majority of world leaders and key stakeholders that much more needs to be done, if the ambition of keeping global warming to a 1.5-degree increase is to have any chance of being met.